Abstract LB340: Mechanism-based trial matching reveals a 54% target alignment gap in ovarian cancer: Quantifying the precision-eligible ovarian cancer patients
Year: 2026
Type: conference-abstract
Source: Cancer Research
Author: Fahad Kiani
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154741358
Cites:
Cited by:
Related to:
